Evidence-based assessment report 2009/003
This report provides summaries of:
• National Institute for Health and
Clinical Excellence (NICE) technology appraisals published since
April 2009 and information on all forthcoming multiple technology
appraisals (MTAs) currently on the NICE work programme to enable
forward planning
• NHS Quality Improvement Scotland
(NHS QIS) HTA programme and related implementation activity
• Other UK and international HTAs
• Centre for Evidence-based Purchasing
(CEP) reports
• Scottish Intercollegiate Guidelines
Network (SIGN) guidelines
• NHS Health Scotland Scottish
perspectives on NICE public health guidance
• NICE interventional procedures.
For MTAs produced by NICE, the NHS QIS
HTA programme, other UK and international HTAs and CEP reports,
summaries outline the technology under consideration, patient and
comparator groups and highlight the key clinical and cost
effectiveness results and any patient/safety issues. Summaries
conclude by providing background on Scottish context and directing
SHTG members to existing sources of evidence.
NICE MTAs are processed by NHS QIS to
establish whether the recommendations are valid for Scotland. For
such MTAs, NHSScotland should take account of the NICE guidance and
ensure that recommended drugs and treatment are made available to
meet clinical need. NICE has provided costing statements and audit
support tools to support implementation in England. These are
summarised to assist implementation in Scotland.
All other sections of the report are
for information only.
Published Date: 18 August 2009
